UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
Introducing deCODEme Cardio™ and deCODEme Cancer™
Focused Genetic Scans Offer Individuals a New Way to Better Understand their Risk of Cardiovascular Disease and Common Cancers Reykjavik, ICELAND, January 18, 2009 – Through deCODEme™, the world’s first first retail genome analysis service, deCODE genetics...
Stories from Our Foremothers: deCODE Publishes an Unparalleled Genetic Snapshot of Iceland 1000 Years Ago
Reykjavik, ICELAND, January 16, 2009 – In a paper published today scientists at deCODE genetics (Nasdaq:DCGN) present the results of the largest study of ancient DNA from a single population ever undertaken. Analyzing mitochondrial DNA, which is passed from mother to...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.